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 Abstract 
Expedited Partner Therapy (EPT) is an important strategy in reducing reinfection for clients with 
a positive chlamydia or gonorrhea lab test.  It also reduces the time it takes to treat partners, 
therefore decreasing the rapid spread of these diseases.  In 2012, the Alaska Section of Public 
Health Nursing began to establish an EPT process.  The purpose of this program evaluation was 
to determine uptake in EPT clinical services and to identify barriers both in the process and in 
staff knowledge and support of EPT practice.  Several methods of data collection were used 
including historical data review, focus group discussion and online survey.  Based on the data 
review, EPT was offered to only 13.7% of clients with a positive chlamydia and/or gonorrhea 
tests, although of the clients who used EPT, 94.7% reported that using EPT was a positive option 
for them.  Both the focus group discussion and online survey demonstrated that the process set 
up for provision of EPT by public health nurses was lengthy and difficult for staff to follow.  
There were also barriers with nurses using EPT due to fear of a potential allergic reaction 
(35.4%) and fear it could increase antimicrobial resistance (12.5%).  The recommendations made 
were to:  reduce the number of required steps of the process for providing EPT to clients; provide 
ongoing education on evidence-based reporting of EPT services; and to provide support for the 
public health nurse staff.  
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 Chapter 1:  Introduction and Background 
 In 2012, the Alaska Section of Public Health Nursing (SOPHN) formed a team to begin 
exploring the use of Expedited Partner Therapy (EPT).  An internal policy was developed and 
approved, as well as a medical directive to allow Public Health Nurses (PHNs) to deliver EPT to 
clients.  An online educational training was developed and provided to staff using webinar 
technology.  Additionally, the training was recorded and archived for those who were unable to 
attend the live webinar.  The first dose of EPT was given by a State of Alaska PHN in October of 
2013. 
Since its inception in the SOPHN, the use of EPT to treat partners has been low, despite 
the SOPHN’s continued support of EPT both financially and in policy.  The reasons for the 
under-utilization of EPT service are not clear.   Evaluation of the program is necessary to begin a 
quality improvement process and potentially increase the use of EPT. 
Chlamydia trachomatis (CT) infection is the most common reportable disease in the 
United States. (Centers for Disease Control and Prevention [CDC], 2014).  Approximately 75% 
of untreated chlamydia infections contribute to pelvic inflammatory disease, preterm labor, 
ectopic pregnancy, and/or subsequent infertility in women.  Infected men are at risk for 
epididymitis and Reiter’s syndrome.  Infants born to chlamydia positive mothers can suffer from 
conjunctivitis and chlamydial pneumonia (Cecere & Jones, 2014a).  Neisseria gonorrhoeae (GC) 
infection can cause serious complications when not treated, but can be cured with the right 
medication.  The GC rates, although very low relative to the 1970s and 1980s, are relatively 
steady and in some states are on the increase.  Untreated gonorrhea is a major cause of pelvic 
inflammatory disease and ectopic pregnancy in women, and can lead to infertility.  Among males 
with gonococcal infection, epididymitis and infertility may occur.  Infants born to GC positive 
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 mothers are at risk for conjunctivitis requiring treatment with antibiotics (Cecere & Jones, 
2014b). 
 Effective clinical management of clients with chlamydia and/or gonorrhea requires 
treatment of their current and recent sex partners to reduce reinfection rates, and to stop rapid 
transmission of the sexually transmitted diseases (STDs).  Typically, an interview with the 
infected individual is conducted and names of recent sexual partners are elicited.  The provider 
can then outreach to the contacts directly to advise them in a confidential manner that they have 
been named as a sexual contact to someone with an STD.  Counseling on treatment and further 
testing options is given at this time.   Although this provider-assisted method is considered the 
optimal strategy for partner notification, it requires a considerable amount of time to outreach to 
all contacts by the provider.  Additionally, clients may be reluctant to disclose the names of 
his/her partner(s).  They may also state their partner(s) will not come in for treatment or testing 
due to stigma of being seen at a public health center, or they have a lack of transportation, or a 
lack of concern about being infected. 
 One option that has been shown to be effective in partner notification and treatment is the 
use of EPT (CDC, 2006).  This method allows the provider to give either a prescription or 
medications to the infected individual to give to his/her partner(s) without requiring the 
partner(s) to be seen at the clinic.  Contacts should also receive information on the safe use of the 
medication, resources for further testing, and education on prevention of STDs in the future.   A 
study done by Golden et al. (2007) with the King County Health Department found that the 
estimated percentage of person with GC or CT infection for whom all partners were treated rose 
from 39% to 65% concurrent with the institution of their EPT program.  Expedited partner 
therapy represents a strategy to facilitate partner management in addition to provider-assisted 
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 referral.  According to Hogben, Kidd & Burstein (2012), EPT has been in existence informally 
for decades.  In a large retrospective analysis in New York City, 54.8% of clients, overall, 
accepted EPT when offered, demonstrating a high level of acceptance by the public (Vaidya, 
Johnson, Rogers, Nash & Schillinger, 2014).  However, in one study done at five pediatric 
clinics in Oak Lawn, Illinois, only 25% of physicians utilized EPT in their practice, 
demonstrating a low rate of acceptance in providers seeing high risk teens (Mears, Kelly, 
Kaviany, Reggi & Amidon, 2014). 
In May, 2005, Dr. John M. Douglas, Jr., Director of the Division of STD Prevention at 
the CDC, sent all licensed U.S. medical providers a “Dear Colleague Letter” supporting and 
encouraging EPT as a useful option to facilitate partner management for both chlamydia and 
gonorrhea infections.  Dr. Douglas, Jr. further directed the preparation of a report published and 
distributed as support and guidelines for the use of EPT (CDC, 2006).  Over the next several 
years, professional organizations began to issue supportive statements and position papers.  
These organizations included the American Medical Association, Society for Adolescent 
Medicine, American Academy of Pediatrics and the American College of Obstetricians and 
Gynecologists. 
Alaska has consistently had the first or second highest chlamydia rate in the United States 
since 2000 (Cecere & Jones, 2014a).  In 2008, an increase in gonorrhea infection was discovered 
in the Southwest region, and it continued to increase over the next two years, ranking Alaska 
with the third highest gonorrhea rate in the nation (Cecere & Jones, 2014b).  In 2010, the State of 
Alaska’s Section of Epidemiology (SOE) worked with health clinicians at the local, state and 
federal level to determine response activities that could combat the increasing rates of both 
chlamydia and gonorrhea, including the use of EPT (Cecere, Senft & Jones, 2011). 
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 Although state law did not prohibit EPT in Alaska, in September 2010, the State Medical 
Board modified regulation 12AAC40.967 to formally sanction its use in Alaska by Physicians 
and Physician Assistants.  Specifically, the new regulation states that “Unprofessional conduct 
includes the following: …(20) prescribing, dispensing, or furnishing a prescription medication to 
a person without first conducting a physical examination of that person, unless the licensee has a 
patient-physician or patient-physician assistant relationship with the person; this paragraph does 
not apply to prescriptions written or medications issued (A) for use in emergency treatment; (B) 
for expedited partner therapy for sexually transmitted diseases.”  [Alaska Administrative Code 
title 12, § 40.967(29)(B)].  By January 2012, the Alaska Board of Nursing made a policy 
statement to allow for EPT by Advanced Nurse Practitioners.  These legal moves paved the way 
for Alaskan health providers to offer EPT services to local residents. 
A full assessment of knowledge and attitude surrounding EPT use in Alaska was 
conducted by the CDC and Alaska Section of Epidemiology beginning in May 2010, (Cecere & 
Jones, 2010) and the findings were subsequently published in January 2011.  Knowledge, 
attitudes and practices of EPT among policy makers, health care providers and clients were 
determined in this report.  Surveys and interview findings indicated that EPT was considered an 
acceptable partner management tool.  In fact, 88% of respondents agreed that EPT would 
decrease the spread of STDs in Alaska (Cecere, Senft & Jones, 2011).  Sixty percent thought that 
EPT should be considered the standard of care, while 28% agreed with the statement that EPT 
was too dangerous without knowing the partners’ allergy/medical histories.  The next step was 
the development of a plan for promoting the implementation and evaluation of EPT services as a 
tool to reduce the STD epidemic in Alaska and to mitigate the burden of morbidity from 
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 untreated chlamydia and gonorrhea.  Furthermore, several important recommendations for EPT 
implementation were identified and addressed (Cecere, Senft & Jones, 2011): 
1. Health care providers should consider using EPT to treat contacts to CT and/or 
GC. 
2. Health care providers should formulate policies and procedures for use of EPT. 
3. Symptomatic partners receiving EPT should be encouraged to seek medical 
attention. 
4. Health care providers should ensure that EPT medications are available for their 
use. 
5. Providers must still report confirmed infections to the Alaska Section of 
Epidemiology. 
In March 2012, based on these recommendations, SOPHN formed a team to investigate 
the potential use of EPT by public health nurses and advanced nurse practitioners.  Included in 
this team were two regional nurse managers, one health practitioner, one nurse manager, two 
advanced public health nurses (PHN IIIs) and one nurse consultant.  A Gantt chart was created to 
communicate the project timeline and to monitor progress of the workgroup. 
The team reviewed and followed the guidance in the CDC publication “Expedited Partner 
Therapy in the Management of Sexually Transmitted Diseases”, which served as a reference 
document for guidelines and program implementation.  The team also identified other 
organizations and states that had successfully implemented EPT, including an Alaskan tribal 
organization that had successfully implemented an EPT program in their outpatient clinic.  
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 Interviews were conducted with the tribal organization staff and resources were shared including 
patient handouts, policies and medical directives. 
The team reviewed the information, presented the findings and proposed a plan to offer 
EPT for public health clients to SOPHN nursing senior leadership.  Following consultation with 
the Section of Epidemiology, a decision was made to implement an EPT program in Public 
Health Nursing.  Several documents were required prior to pilot testing, including medical 
directives, policies and procedures, charting guidelines and patient handouts.  A comprehensive 
plan to provide education for all public health nurses was developed.  This included a recorded 
webinar and learning modules in Moodle for tracking public health nurse participation. 
The SOPHN process required for providing EPT to clients included the following steps: 
1. The clients must have a documented positive lab test for CT and/or GC. 
2. Standardized charting was developed and must be followed exactly to allow the 
nurse informatics team to demonstrate accurate rates of utilization of EPT. 
3. The number of doses is provided for all sexual contacts in the past 60 days, and 
written education sheets are given to the client for each partner. 
4. All clients are contacted by phone 10 days later to assure the medications were 
given to their sexual contacts. 
5. During this 10 day phone call, two questions are asked for assessing client 
satisfaction. 
6. Another STD test for reinfection is done after 90 days. 
7. If a client does not show up for the 90 day test of reinfection, or there is not an 
appointment scheduled, the nurse will outreach to the client by phone. 
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 A client seen with a positive CT and/or GC lab test is assessed by the PHN for eligibility 
for EPT, and two groups of clientele are not considered eligible.  Clients who disclose intimate 
partner violence may be at increased risk for escalating violence by providing EPT to their 
partner.  Also, men who have sex with men are at an increased risk of other STDs such as 
Hepatitis C and HIV or AIDS, and therefore are recommended to come to the clinic for a full 
STD screening. 
Initially, four health centers were identified as pilot sites for EPT services during the first 
quarter of the 2013 fiscal year (FY 2013).  All public health nurses at these locations participated 
in the training and educational activities, and were given the opportunity to provide feedback to 
the EPT team via a survey.  Pretests and posttests were completed in Moodle (online training 
system), which clearly demonstrated increased knowledge regarding the EPT program 
components.  The pretest mean score was 61.62% with a standard deviation of 17.52 and the 
posttest mean score was 93.12% with a standard deviation of 6.55. 
The first dose of EPT was distributed at one of the pilot sites in October 2013.  Also 
during this time, all PHNs statewide were required to participate in the training and EPT was 
provided statewide by January 2014.  The EPT program has now been operating for over two 
years.  The senior leadership for SOPHN was interested in an evaluation of this program.  Some 
concerns have been that the use of EPT is minimal and perhaps limited due to resistance by 
health center or even by individual PHNs.  Changing health care practices can be difficult and 
may be hindered by a provider’s attitudes, ideas and practices.  Practice uncertainty occurs when 
health care providers are uncomfortable as a result of unfamiliar or challenging patient care 
situations (Grol & Grimshaw, 2013).  This program evaluation was to determine if practice 
uncertainty has occurred and what areas of change require further education and support. 
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 Chapter 2:  Project Goals and Objectives 
The goal of this project was to evaluate the process and outcome of the State of Alaska 
SOPHN EPT Program in order to improve their service delivery to control and prevent 
chlamydia and gonorrhea in Alaska.  It was critical that data be collected to determine the 
feasibility of continuing to offer EPT to public health center clients.  A full process evaluation 
was needed to provide important information for the SOPHN to be able to develop an 
improvement plan for this program. 
The project objectives were to: 
1. Assess program fidelity and the implementation process. 
2. Review records and collect data on the use of EPT by State PHNs and 
compliance with client follow-up and testing protocols between October 1, 
2012 through January 31, 2015 to quantify the number of EPT services. 
3. Conduct a focus group discussion (FGD) of the original members of the 
EPT team to elicit potential barriers in using EPT to incorporate in the 
PHN survey.   
4. Conduct an online survey of PHN staff to identify barriers with the EPT 
Program, and PHN knowledge, satisfaction, attitudes and beliefs about the 
use of EPT. 
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 Chapter 3:  Methods 
This program evaluation included a mixed method approach, both qualitative and 
quantitative, for data collection.  Quantitative data were extracted from the SOPHN Resource 
and Patient Management System (RPMS) database.  As discussed earlier, these data were 
dependent on the nurse documentation of EPT services using standardized charting, which was 
provided during staff education.  The data requested from the nursing informatics team included 
number of clients receiving EPT, whether standardized charting was used for each step, number 
of 10 day phone calls, results of the satisfaction questions, number of 90 day phone calls and 
number of 90 day tests of reinfection.  Qualitative data were collected using an FGD and an 
online survey.  
Diffusion of Innovation Theory 
The Diffusion of Innovation (DOI) Theory was developed by E.M. Rogers in 1962.  This 
is one of the oldest social science theories.  It explains how, over time, an idea gains momentum 
and spreads through a population or system.  The end result is that people adopt a new idea, 
product or behavior.  The key to adoption is that the individual must perceive the idea, product or 
behavior as new or innovative, making diffusion possible.  The introduction of EPT in public 
health centers was not only a new idea, but it required the PHNs to modify their behavior in the 
clinic when providing STD services.   
Adoption of an innovation doesn’t happen simultaneously in a system, rather it is a process 
whereby some people are more apt to adopt the changes that others.  There are five categories of 
adopters, and when promoting an innovation, there are different strategies used to appeal to the 
different adopter categories. 
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 1. Innovators – These are people who are first in line to adopt the changes.  They are excited 
about new ideas and are often willing to take risks in developing new ideas.  Little action 
needs to be done to appeal to this category.  The PHN innovators would readily adopt the 
new EPT process and begin to offer this service to clientele when the program began. 
2. Early Adopters – These individuals are opinion leaders, they embrace change 
opportunities.  They are aware of the need to change and are comfortable with adopting 
new ideas.  Strategies to entice this group include how-to manuals and information on 
implementation for the new changes.  Following the education that SOPHN provided to 
all PHN staff, the early adopters would begin implementing the EPT process into their 
practice. 
3. Early Majority – These people are rarely leaders, but they will adopt new ideas before the 
average person.  They typically will need to see evidence that the innovation works 
before they are willing to adopt it.  Strategies that support this category include sharing 
success stories and evidence of the effectiveness of the innovation.  Once the EPT 
program was beta tested in the four communities, the early majority adopters would 
benefit from hearing how these PHNs implemented EPT successfully and how positive 
their clients responded in the satisfaction survey. 
4. Late Majority – These individuals can be skeptical of change, and typically will only 
adopt an innovation after it has been tried by the greater majority.  Strategies to appeal to 
this population include information on how many others have tried the changes and have 
been successful.  As the EPT program continued, the late majority PHNs could be 
inspired to implement the process into their practice with updates from successful users 
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 over time.  Quarterly statistics on uptake and client satisfaction would be beneficial to 
this group. 
5. Laggards – These people are bound by tradition and are very conservative.  They remain 
skeptical of change and are the most difficult group to adopt changes.  Strategies for this 
population include statistics and peer pressure from other adopter groups. Identification 
of successful PHNs using EPT in their practice may be helpful in convincing this 
reluctant group to try the process, perhaps by closely mentoring the nurse when seeing a 
client in the clinic (Figure 1). 
 
Figure 1:  Diffusion of Innovation Theory Categories of Adopters 
 The stages in which a person adopts an innovation are also defined in the DOI Theory.  
These include awareness of the need for change, decision to adopt (or reject) the innovation, 
initial use or testing of the innovation, and continued use of the innovation.  There are also five 
factors that influence the adoption of the innovation, each which affect the individual to a 
different extent in the five adopter categories. 
1. Relative Advantage – The degree to which the innovation is seen as better than the idea, 
product or program it is replacing.  For EPT, a close comparison of traditional 
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 confidential contact investigation and the process of providing EPT medications would 
be helpful in defining the advantages in using this new strategy. 
2. Compatibility – How consistent the innovation is with the experiences and needs of the 
adopters.  Adult learning theories support the need to assess where the new user is with 
their past experiences and their knowledge base prior to offering education.  There may 
be staff that has used EPT in previous jobs, and they may have different needs compared 
to new PHNs.  
3. Complexity – How difficult the innovation is to understand and to use.  As discussed 
earlier, the process for providing EPT has several steps and requires staff to track the 
client over three months, so it can be complicated. 
4. Trialability – The extent in which the innovation is tested and trialed before a 
commitment to adopt the changes can be made.  The EPT program was beta tested in four 
communities, but only for two to three months before it was to be implemented statewide.   
5. Observability – The extent in which the innovation provides positive and measurable 
results.  This evaluation is the first one done for the EPT program, so it is difficult to 
measure results to share with staff. 
The DOI Theory aptly describes the process in changing how public health nurses can 
embrace the changes from doing traditional confidential contact investigations, to providing EPT 
to clients with positive sexually transmitted diseases.  It also gives the SOPHN information on 
some strategies that can be used to influence different groups of adopters to make changes and 
adopt this new innovation.  Although this theory did not originate in public health, it has been 
used successfully in many fields.    The most successful adoption of a public health program 
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 results from understanding the target population and the factors which influence their rates of 
adoption. 
Study Population and Sample 
In the state of Alaska there are four regions, which include 21 health centers and 121 
PHNs.  These PHNs provide services in the health centers as well as itinerating to 256 villages in 
Alaska. For this evaluation the target population was the SOPHN (Figure 1). 
 
Figure 2: Alaska Section of Public Health Nursing Regions  
Protection of Human Subjects 
  Before beginning this evaluation, the researcher completed ethical research training and 
earned Collaborative Institutional Training Initiative (CITI) certification (Appendix A) and the 
University of Alaska Anchorage Institutional Review Board (IRB) reviewed and approved this 
project.  De-identified data were provided by the nurse informatics team to the investigator.  For 
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 the FGD, informed consent was obtained electronically using a poll before the FGD (Appendix 
B).  The online survey was conducted using Survey Monkey and the settings were for 
anonymous data collection.  Informed consent was obtained in the first question, and those who 
declined were exited from the survey (Appendix C). 
Data Review  
 The RPMS database is a robust healthcare system used by Indian Health Services 
nationwide.  Public Health Nursing has been using this system since the mid 1980’s.  The 
SOPHN nursing informatics team gathered and provided data with no patient identifiers to the 
principal investigator.  These data, between October 1, 2012 and January 31, 2015, included the 
following: 
• Number of clients receiving EPT. 
• Number of doses of EPT given to all clients statewide. 
• Number of doses of EPT given/not given to partners. 
• Number of follow up phone calls to clients 10 days after EPT provided. 
• Number and results of retests completed at 90 days after EPT provided (reinfection 
rate). 
Focus Group Discussion 
The FGD consisted of seven of the eight original members of the EPT team for SOPHN.  
Informed consent was collected electronically by including the consent as a poll using 
GoToWebinar technology (Appendix B).  This team was critical in initiating the EPT program in 
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 Alaska and each member is a subject matter expert.  It was important to identify potential 
barriers for the PHN staff in providing EPT to include in the follow up survey of PHN staff.  A 
FGD question guide of topic areas was developed and used to prompt further, more in depth 
discussions (Appendix D).  GoToWebinar technology was used to hold the FGD since the EPT 
team resided and worked in locations throughout the state.  The FGD was recorded digitally and 
transcribed by the researcher later.  The FGD facilitator began with a brief introduction of the 
proposed program evaluation, and as themes developed around potential barriers, the facilitator 
clarified and restated the issue for group consensus.  Once the recording was transcribed, 
thematic analysis was applied and common themes were identified. 
Survey of Public Health Nurses 
An online survey was developed to determine strengths, weaknesses and barriers of 
providing EPT to SOPHN clients (Appendix E).  The evaluation questions assessed staff 
education and comfort level when talking with clients, belief in the safety of EPT, confusion in 
the process, and barriers to documentation.  The majority of the questions were multiple choice.  
Select questions were open-ended and comment boxes were provided as well. The tool was pre-
tested with a small number of the SOPHN nurses representing all four of the SOPHN regions.  
Once vetted, the survey was sent to all PHNs statewide.  This survey was set for anonymous data 
collection to protect confidentiality of the nurses participating.  Informed consent was obtained 
electronically, and those who declined were exited from the survey (Appendix C).   At this time, 
123 public health nurses and advanced nurse practitioners were employed by the SOPHN.  By 
policy, PHNs are expected to introduce EPT to their clients and offering EPT for partner 
treatment. 
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 Data Analysis of SOPHN EPT Services 
The RPMS data on EPT services provided by SOPHN between October 1, 2012 and 
January 31, 2015 were provided from the SOPHN nurse informatics team in a list format.  Each 
of the required steps per policy was measured to determine if it was done and if it was 
documented using standardized charting. 
The FGD was digitally recorded and transcribed at a later date by the researcher.  
Thematic analysis was performed to identify themes; underutilization of EPT, process deviation 
and EPT process management.   
The online survey data were collected and analyzed in Survey Monkey.  The survey 
remained open for three weeks, and a reminder email was sent to all staff one week prior to 
closing.  The data was then exported into an Excel spreadsheet for further analysis.   
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 Chapter 4:  Results 
Data Review of SOPHN EPT Services between October 1, 2012 and January 31, 2015 
Of the 123 public health nurses and advanced nurse practitioners, 55 responded, for a 
45% response rate.  During the time period of October 1, 2012 through January 31, 2015, there 
were 15,752 PHN visits for STD services throughout the state of Alaska.  Of these, there were 
1,315 positive cases of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) infections.  
The overall positivity rate for testing was 8.34%.   Of the positive cases, 88.97% were CT and 
11.03% were GC (Table 1). 
Table 1:  Positive CT and/or GC for Alaska Section of Public Health Nursing  
From October 1, 2012 through January 31, 2015 
 
STD N (total) Sex N (males) Sex N (females) 
Positive CT 1,170 Males 485 Females 685 
Positive GC 145 Males 90 Females 55 
Total Positive CT and/or GC 1,315 Males 575 Females 740 
  
 Of the 1,315 clients with positive lab test for CT/GC, EPT services were documented as 
either declined or given in 180 charts (13.7%).  However, of the 180 clients who were offered 
EPT, 154 (85.6%) accepted and only 26 (14.4%) declined (Figure 2). 
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Figure 3:  Public Health Nursing Clients Accepting/Declining EPT When Offered, N=180 
The process for delivery of EPT included steps over a 90 day period of time following the initial 
clinic appointment.  These steps include standardized documentation of EPT service, phone call 
to ensure the client gave the medication to his/her partner after 10 days, a client satisfaction 
survey during the 10 day phone call, a reminder call at 90 days to return for retest, and the retest 
appointment 90 days after EPT was given.  With each step of the process, completion rates 
declined (Figure 3). 
86% 
14% 
Clients Offered EPT 
Client Accepted EPT Client Declined EPT
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Figure 4:  Steps of the EPT Process Completed for Public Health Nursing (N=154) 
 Clients are eligible for EPT services as long as they are not in an interpersonal violence 
(IPV) situation, as disclosure of an STD to their partner could escalate violence.  It is also not 
recommended for men having sex with men (MSM) due to the high risk of concurrent STDs 
such as Hepatitis C and Human Immunodeficiency Virus (HIV).  These individuals are 
encouraged to come to the clinic for further testing and treatment.  The SOPHN rate of IPV 
disclosure is 1.25% of all clients receiving clinical services, and PHNs do not see a large number 
of MSM individuals.  Therefore, the rate of 180 out of 1,315 (13.7%) clients with positive 
CT/GC labs who were offered EPT and either accepted it or declined was very low.  However, it 
could be a matter of documentation as well, especially for those who declined the service.  It 
could also be explained if the partner had already been treated, the partner was in the clinic with 
them today or had already been treated, they prefer the medication be delivered by the clinician, 
46.1% 
42.2% 
24.7% 
10.4% 
0.1% 
PHN used standardized charting when giving
EPT
PHN completed the 10 day phone call
Client completed the satisfaction survey
PHN Completed the 90 day phone call
Client returned in 90 days for retest
Steps of the EPT Process (N=154) 
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 or they were no longer with their partner (Vaidya, Johnson, Rogers, Nash & Schillinger, 2014).  
In each of these scenarios, EPT would not be appropriate and therefore would not be offered or 
declined.  
 The SOPHN process for follow up of EPT clients by PHNs includes a phone call at about 
10 days following the EPT appointment to assess if the medication was given or not.  Only 65 of 
the 154 EPT clients (24.7%) were called and had documentation according to standardized 
charting.  During this call, two questions were asked to assess client satisfaction.  The overall 
number of clients with documented satisfaction surveys was 38 out of 154 (24.7%). 
 Out of the 38 clients who responded to the questions, client satisfaction was very high.  A 
total of 97.4% of clients felt prepared to give their partner the medication, and 94.7% stated that 
using EPT was a good option for them. 
 The CDC recommends a test of reinfection be done about 90 days after a client receives 
treatment for CT and/or GC, regardless of whether they accept EPT or not.  Standardized 
charting for this appointment was part of the education and plan for this service.  A total of 16 of 
the 154 EPT clients (10.1%) had been called to remind them of this retest, and there was only 
one documented retest lab done in the clinic.  However, 36.4% of clients did have another 
CT/GC lab test in the clinic within one year for other reasons including symptoms of STI, 
contact to an STI or routine testing.  Of these 26.8% were positive for an STI, and 71.4% were 
now negative.   
Focus Group Discussion Results 
 The FGD was facilitated to open the discussion about use of EPT and to identify potential 
barriers.  The group included six of the seven public health nurses who were part of the original 
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 planning committee.  One member has since left public health nursing and did not participate. 
The discussion was conducted using webinar technology as the participants are from all four 
regions and located around the state of Alaska. 
 Several themes were identified using thematic analysis upon reviewing the recorded 
guided discussion, such as overall underutilization of EPT, process deviation, and EPT process 
management.  The first theme that emerged was on underutilization of EPT overall.  One 
comment from a team member was “I don’t think it is being used to the extent that it should be 
used.  Just looking at the numbers for how much it is used and how much CT there is in AK I 
don’t think it is being used enough.”  Another PHN stated “I think my initial thoughts were that 
it would start off very slowly in terms of uptake but would gradually start to increase as staff 
becomes more familiar with the process…But when we put together the information for the 
CDC, their feedback to us was that slow uptake is what they’ve seen in other states but when 
nurses became more comfortable with the process it goes up.  And it surprised me we haven’t 
seen that.” 
 The next theme was process deviation related to a lack of comfort or confidence in the 
process as it is currently set.  One PHN stated “I do think it’s being followed somewhat, there is 
a lack of comfort with it on the PHN side which is probably why it is being underutilized.”  
Another comment was “As a nurse, I still have a hard time wrapping my head and I talked a lot 
with other team members about this. How can I do this, who would qualify…One of the barriers 
to me would be still in my head figuring out who would be the candidate?” 
 The final theme was regarding EPT process management.  All PHNs were trained to 
follow a set of steps as defined by policy for each EPT client. This process included standardized 
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 charting for all encounters, a phone call at 10 days, and a test of reinfection at 90 days.  One 
comment reflected an initial strong start to introducing staff to EPT: “In the beginning I was 
talking with my NMs [nurse managers] with questions, but we haven’t been doing that lately.  
My assumption is that the process is being followed.”  Another PHN stated “I am not in the 
clinic but I am doing a lot of chart audits so I should be able to tell, and it doesn’t look like a lot 
of clients are being assessed”.  Finally, one statement was “But are they assessing everyone that 
comes in that could use it, [then I would say] no.”  
Online Survey of Public Health Nurses 
 Survey Monkey was used to collect information from the clinic PHNs and managers (see 
Appendix B).  The objective was to identify barriers, strengths and weaknesses of the current 
EPT program and process.  Due to vacancies, there were a total of 97 PHNs at the time of the 
online survey.  Of these, 55 surveys were completed and collected, resulting in a 56.7% response 
rate.  Of those who participated, 90% had completed the live or recorded training on providing 
EPT, and of those trained, 88.6% felt they were prepared to use EPT in their clinical practice. 
 Approximately 39% (38.8%) of respondents had never given EPT to a client, indicating 
there may be some practical reasons and barriers in providing EPT.  These PHNs were then 
asked why they had not given EPT medications to a client.  Reasons and barriers listed from the 
19 PHNs who have never given EPT are shown in Table 2. 
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Table 2:  Reasons Given by Public Health Nurses for why EPT was Never Given 
Reasons why the PHN had not given EPT Response 
Count 
(N=19) 
Response 
Percent 
I have not seen a client with a positive STI 13 68.4% 
My clients have all declined EPT 5 26.3% 
I have not been trained in STI/EPT services 2 10.5% 
My position is not clinical 2 10.5% 
Partners have confirmed treatment at other 
clinics 
1 5.3% 
I don't believe in EPT 0 0.0% 
  
One survey comment was that they had not given EPT because they had been able to 
successfully elicit partner names.  Another stated that there were too many rules in order to give 
EPT. 
When asked if they felt EPT was being used fully to the extent it should be in SOPHN, 
only 52% (29) agreed/strongly agreed.  Another 22% (12) were neutral, and 26% (14) 
disagree/strongly disagree.   
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Figure 5:  Public Health Nursing Perception of Utilization of EPT in SOPHN (N=55) 
 
Specific barriers to use were then elicited from the respondents.  Respondents were given 
a list of the steps per policy for providing EPT to clients, and asked to rate the difficulty in 
completing each step (No barrier, moderate barrier, strong barrier).  There was also the option to 
answer “I have never done this”, for PHNs who had not given EPT to clients (Table 3). 
 
 
 
 
 
 
Strongly Agree 
18% 
Agree 
34% Neutral 
22% 
Disagree 
22% 
Strongly Disagree 
4% 
Please respond to the following statement:  EPT is being used fully to the 
extent it should be in SOPHN. 
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 Table 3:  Barriers in EPT Process for Public Health Nurses (n=49) 
Statement Barrier No Barrier Never Done 
Completing the 90 day retest appointment 23 (46.9%) 9 (18.3%) 17 (34.7%) 
Developing a reminder system for tracking the EPT 
process 
22 (44.9%) 12 (24.5%) 15 (30.6%) 
Completing the 10 day phone call 19 (38.8%) 15 (30.6%) 15 (30.6%) 
Completing the 90 day phone call 19 (38.8%) 14 (28.6%) 16 (32.7%) 
Standardized charting 10 day phone call 17 (34.7%) 17 (34.7%) 15 (30.6%) 
Standardized charting 90 day retest 19 (38.8%) 14 (28.6%) 16 (32.7%) 
Providing EPT medications for named partners 10 (20.4%) 31 (63.3%) 8 (16.3%) 
Defining Eligible clients for EPT Services 10 (20.4%) 30 (61.2%) 9 (18.3%) 
Explaining EPT services to clients 2 (4.0%) 39 (80.0%) 8 (16.2%) 
 
Other concerns included a decrease in the opportunity to screen for other STIs because of 
the missed opportunity to see the contacts in the clinic.  There was also mention that PHNs 
should first attempt to encourage partners to come in for an appointment to get the best care, and 
that EPT should be a last resort for those who cannot or will not come in for treatment.  Another 
comment was that clients would keep the medication and take it when they think they have 
CT/GC symptoms again. 
Barriers for using EPT can often be provider beliefs and concerns (Golden & Estcourt, 
2011).  These reasons can be fear of antimicrobial resistance, allergic reactions and legal 
recourse, as well as internal concerns of increased clinical time and difficulty following 
procedures.  Provider hesitancy in offering and using EPT with their clientele was then addressed 
(Table 4).   
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 Table 4:  Other Concerns/Barriers for EPT Use by Public Health Nurses (N=49) 
Answer Options Response 
Percent 
Response 
Count 
Increased amount of 
clinical time to use EPT 
instead of traditional contact 
investigation 
6.3% 3 
Difficulty tracking 
client through the 90 day 
retest appointment 
60.4% 29 
Difficulty following 
standardized charting for EPT 
8.3% 4 
Fear of giving 
medications due to potential 
allergic reaction 
35.4% 17 
Fear it would increase 
antimicrobial resistance 
12.5% 6 
Concerns regarding 
the legal aspects of EPT 
12.5% 6 
No other concerns in 
using EPT 
29.2% 14 
Other (please explain) 8 
 
Again, 60.4% cited the difficulty of tracking clients through the 90 day retest 
appointment as a major concern.  Another 35.4% have a fear of an allergic reaction in the 
partner.  Additionally 12.5% of PHNs stated concerns with increasing antimicrobial resistance as 
well as a fear over the legality of providing EPT in Alaska. 
Finally, participants were asked to list recommendations for improving the EPT process.  
Suggestions included building a report into RPMS to include training for PHNs on how to use 
the report as a tool for identifying clients due for 10 day or 90 day follow up.  There were four 
comments that suggested annual training; and, specifically to address concerns and possible 
barriers for PHNs to provide EPT services.  Finally, there were requests to simplify the process 
to make it easier to follow the process or reduce the number of steps overall. 
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 Chapter 5:  Discussion 
The results of this process evaluation indicate that the uptake of EPT services by PHNs is 
lower than expected or desired.  As mentioned in the results section, of the 1,315 clients with 
positive lab test for CT/GC, EPT services were documented as either declined or given in 180 
charts (13.7%).  A large study of CT infected individuals in New York City from 2011 to 2012 
demonstrated an uptake rate for use of EPT for partner notification of 54.4% (Vaidya, Johnson, 
Rogers, Nash & Schillinger, 2014).  This indicates that use of EPT in public health in Alaska is 
underutilized.  Barriers to using EPT in the clinic can be summarized as difficulty following the 
process and provider concerns and hesitancy. 
Of 1,315 positive labs for CT and GC only 180 had documented that EPT was offered, 
and subsequently declined or given.  Most clients that are seen at the clinics are eligible for the 
services, since only those who disclose IPV or are men having sex with men are ineligible.  Less 
than 2% of clients disclose IPV, and we do not see a high number of MSM clients; so there 
should be a much higher rate of EPT declines.  Therefore, the PHN is either not offering EPT to 
all eligible clients, or they are not documenting it using standardized charting.  Another reason 
could be that the client’s partner is with them in the clinic that day, or that they were treated 
already.  Finally, clients may decline EPT if they are no longer with their partner. In the study by 
Vaidya, Johnson, Rogers, Nash & Schillinger, 2014, “excluding person whose partners were 
already treated and person whose partners were in the clinic for treatment, EPT acceptance rates 
were 69.4%.” 
Of the staff responding to the survey, a high number (38.8%) have never given EPT 
medications to a client.  Possibly, there may be super-users, or staff who are more comfortable 
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 with using EPT than others.  Because of staff turnover, there is also a large cohort of new PHNs 
around the state who may not have been trained in treatment for STD’s or in using EPT yet.  
Another reason listed by survey participants was they had not seen a client with a positive STD 
(68.4%).  Some areas in Alaska have a lower incidence of STDs, as well as more community 
partners who offer this service such as Tribal Health, private providers and Planned Parenthood 
clinics.  Also, some health centers have PHNs in certain clinical areas that may not include 
STI/EPT, such as child health or home visiting services. 
Clearly the process is complicated and long, with tracking the client from the time of 
treatment through the 90 day retest.  Original plans were to develop a weekly database report that 
would list all of the EPT clients who were due for the 10 day phone call and the 90 day retest.  
This report is not yet functioning and tracking the clients is problematic.  A few health centers 
have Health Program Associates (HPA), non-licensed personnel that can assist with tracking and 
calling clients.  Some health centers are leaving the tracking up to the PHN who saw the client, 
and the individual PHNs are using paper or electronic ticklers that they have designed.  Other 
health centers have a “nurse of the day” who is responsible for calling clients who are due to be 
seen.  Clearly with low rates of 10 day phone calls and 90 day retests, this process is not working 
well.  The Nurse Informatics team has developed a report that can be helpful, but it is not easy to 
follow and is underutilized by staff.  Finally, with a highly transient population around the state 
of Alaska, locating clients 90 days after an appointment can be challenging. 
Although the literature clearly shows that allergic reactions to the medications given for 
EPT treatment are extremely low, this continues to be a barrier for a significant number of staff.  
The risk of increasing antimicrobial resistance is also a concern, but literature reviews show that 
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 this is not occurring and should not be a barrier to EPT.  Finally, concerns over the legality of 
EPT in Alaska were listed although updated laws make it clear that it is legal for use in Alaska.   
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 Chapter 6:  Strengths and Limitations 
 A noteworthy limitation of this study was the small numbers and size of the data sets.  
Also, because of a recent large amount of staff turnover, many of the new PHNs had not been 
trained in STD or EPT services in the clinic, and therefore did not have an opportunity to offer 
EPT to clients during the data collection period of this study.  Finally, STDs are more common 
in some of the regions around Alaska, and less common in others.  Some of the smaller clinics 
see a very limited number of positive CT or GC cases. 
 Time was also a limitation as this quality improvement process was needed by the 
SOPHN to make decisions in the use of EPT with their clientele.  A longer study that looked at 
process over time would have been useful to see if there has been any increase in uptake of EPT 
services. 
 There were several methods used to gather the data in this program evaluation.  If only 
one method had been used it may have produced more focused data and could have been more 
easily summarized.  In retrospect, the FGD data were most valuable and could have been 
conducted with several groups including PHNs who are treating clients with positive STDs.  It 
may have more strongly identified barriers of using EPT and ways to improve the process in the 
future. 
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 Chapter 7:  Public Health Implications 
 The use of EPT in treating partners with positive CT and GC infections has been shown 
to be highly effective in reducing reinfection and in decreasing the amount of time for contacts to 
be treated.  Public health is currently challenged with budget cuts and staffing issues in Alaska.  
Resources for conducting traditional confidential contact investigations are limited.  There are 
only three Health Program Associates (HPAs) with nursing, located in Fairbanks, Mat-Su and 
Nome.  These non-licensed personnel are able to assist the nursing staff with contacting positive 
clients and eliciting names of partners, as well as phone follow up for referrals and treatments, 
including EPT.  In the Section of Epidemiology, there are four Disease Intervention Specialists 
(DIS) located in Anchorage who are able to complete contact investigations.  This makes it is 
more difficult for them to make contact within rural areas, so they often rely on public health 
nurses to do this work.  The Alaska Native Tribal Health Consortium has one DIS worker to do 
any follow up work with their clientele.  Finally, the Municipality of Anchorage Public Health 
Nursing has several nurses who rotate this role that comprises about 1.0 full-time position.  The 
small number of these specialists and the limited number of PHNs in the state demonstrate we 
clearly are not able to effectively complete traditional contact investigations on all positive CT 
and GC clients in the state. 
 The use of EPT is an additional partner management tool to prevent and control STDs, 
and could be a big savings of time over doing confidential contact investigations when used with 
eligible clients in our clinics.  Golden et al. (2006) found the percentage of cases classified as 
having all of their partners treated increased from 39% to 65% with the introduction of an EPT 
program in King County, Washington.  Also, treating contacts more rapidly by providing EPT 
may decrease the prevalence of the disease thereby interrupting the spread of the disease. 
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  This study identified barriers in the process used by PHNs to provide EPT to their clients.  
The online survey revealed some perceived barriers in staff attitude and knowledge surrounding 
the use of EPT in their clinical practices, such as the misperception that EPT may cause 
increased antimicrobial resistance or large numbers of severe allergic reactions.  These lessons 
can be used as a basis for a quality improvement project including continued education within 
the Section of Public Health Nursing.  The information (or data) can also be used by other 
providers considering implementing EPT in their practice. 
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 Chapter 8:  Conclusion and Recommendations 
 As stated in the introduction, the use of EPT is effective in reducing reinfection for 
clients with a positive CT or GC test.  Most clients getting services with the SOPHN are eligible 
for EPT and should be offered this option for treating their sexual contacts.  However, uptake of 
EPT services has been slow.  Because dates of services were not available, it is not possible to 
determine if EPT services have increased over time.  Barriers have been identified and are 
divided into two major categories, program process and provider knowledge and comfort. 
 There are ways to improve the process of EPT provision by making it less difficult for 
staff to understand and to complete.  Listed below are some of the recommendations that will be 
put forward to SOPHN leadership team as a result of this study: 
1. Offer education on EPT annually to staff addressing perceived barriers of concerns over 
possible allergic reactions and/or increasing microbial resistance.  Provide the evidence 
based literature that addresses legal concerns. 
2. Form a quality improvement workgroup to assess the current process and policy, and to 
build in continuous evaluation of the program over time.   
3. Ask the client how many contacts they have had in the past two months and provide them 
EPT for each one without requiring them to disclose names of partners.  This will add an 
additional layer of confidentiality for clientele who may be hesitant to name certain 
contacts, but would be willing to give them the medications if provided. 
4. Work closely with the Informatics Team to develop an electronic tracking tool in RPMS 
to help PHNs follow the policy through the 90 day retest appointment more easily and 
consistently around the state. 
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 5. Review records of EPT given by provider to identify if there are super users who could 
be champions in their clinic and/or region in increasing EPT use by other PHNs. 
6. Investigate alternate ways to contact the client in 10 and 90 days besides by phone.  Some 
ideas might be private messenger, email, regular mail or texting. 
7. Ensure that future evaluation   includes gathering data by region and by date.  This will 
show if there is better uptake of EPT by geographical area or health center, as well as if 
there is an increase in use of EPT over time by the PHNs. 
 Finally, it is recommended that a workgroup be formed to begin a quality improvement 
process that would include an annual review of the EPT program.  A benchmark should be 
considered to track the uptake of EPT use in the clinics.  Managers should review which 
nurses are using EPT and which may not be using it due to barriers and/or educational needs. 
They should work closely with their staff to support the EPT program uptake. 
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 Appendix A:  CITI Certification for Principal Investigator 
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 Appendix B 
 
Evaluation of a Public Health Nursing Expedited 
Partner Therapy Program 
 
INFORMED CONSENT FORM 
 
Principal Investigator: 
Colleen McNulty, BSN, RN 
MPH Student 
Tel: (907) 334-2267 
E-mail: colleen.mcnulty@alaska.gov 
Project Committee Chair/  
UAA Faculty: 
Dr. Nancy A. Nix 
Tel: (907) 786-6590 
E-mail: nanix@uaa.alaska.edu  
DESCRIPTION: 
I am conducting an evaluation of the Expedited Partner Therapy (EPT) program in public health nursing.  
I will be assessing program fidelity and the implementation process.  I am also interested in public health 
nurses knowledge, satisfaction, attitudes and beliefs regarding the use of EPT in their practice. 
 
VOLUNTARY NATURE OF PARTICIPATION: 
Your participation in this study is voluntary.  If you don't wish to participate, or would like to end your 
participation in this study, there will be no penalty or loss of benefits to you to which you are otherwise 
entitled.  In other words, you are free to make your own choice about being in this study or not, and 
may quit at any time without penalty. 
 
CONFIDENTIALITY: 
Your name will not be attached to your interview responses.  Your name and any other identifiers will be 
kept in a locked file that is only accessible to me or my research associates.  Any information from this 
study that is published will not identify you by name. 
 
BENEFITS: 
There will be no direct benefit to you from participating in this study.  The results of this study may 
benefit public health nursing as a quality improvement guide.   
 
RISKS: 
It is possible that the discussion of thoughts or feelings about the use of EPT in public health nursing 
could make you uncomfortable.  However, there are no other known risks to you. 
 
CONTACT PEOPLE: 
If you have any questions about this research, please contact the Principal Investigator and/or the 
Project Committee Chair/UAA Faculty at the telephone numbers listed above.  If you have any questions 
about your rights as a research subject, please contact Sharilyn Mumaw, UAA Research Compliance 
Officer, at (907) 786-1099. 
 
CONSENT: 
Do you consent to participation in a GoToWebinar meeting as a group to discuss Public Health Nursing 
and its Expedited Partner Therapy program? 
 Yes  □                 No  □ 
 
Signature:  _______________________________________ 
 
Date:          _______________________________________ 
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 Appendix C 
 
Evaluation of a Public Health Nursing Expedited 
Partner Therapy Program 
 
INFORMED CONSENT FORM 
 
Principal Investigator: 
Colleen McNulty, BSN, RN 
MPH Student 
Tel: (907) 334-2267 
E-mail: Colleen.mcnulty@alaska.gov 
Project Committee Chair/  
UAA Faculty: 
Dr. Nancy A. Nix 
Tel: (907) 786-6590 
E-mail: nanix@uaa.alaska.edu  
 
DESCRIPTION: 
I am conducting an evaluation of the Expedited Partner Therapy (EPT) program in public health nursing.  
I will be assessing program fidelity and the implementation process.  I am also interested in public health 
nurses knowledge, satisfaction, attitudes and beliefs regarding the use of EPT in their practice. 
 
VOLUNTARY NATURE OF PARTICIPATION: 
Your participation in this study is voluntary.  If you don't wish to participate, or would like to end your 
participation in this study, there will be no penalty or loss of benefits to you to which you are otherwise 
entitled.  In other words, you are free to make your own choice about being in this study or not, and 
may quit at any time without penalty. 
 
CONFIDENTIALITY: 
This survey is anonymous and your name will not be associated with any of your responses. 
BENEFITS: 
There will be no direct benefit to you from participating in this study.  The results of this study may 
benefit public health nursing as a quality improvement guide.   
 
RISKS: 
There are no known risks for your participation in this study. 
CONTACT PEOPLE: 
If you have any questions about this research, please contact the Principal Investigator and/or the 
Project Committee Chair/UAA Faculty at the telephone numbers listed above.  If you have any questions 
about your rights as a research subject, please contact Sharilyn Mumaw, UAA Research Compliance 
Officer, at (907) 786-1099. 
 
CONSENT: 
I consent to participate in this online survey regarding EPT use in public health nursing 
(Click on Yes or No)      □ Yes     □ No (if No, then you will be exited from the survey) 
My continuation with this online survey implies my consent to participate in this study. 
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 Appendix D:  Focus Group Discussion Question Guide 
Focus Group Discussion Questions 
1. Do you think that EPT is being used to the extent it should be in SOPHN? 
2. Do you feel the process is being followed when assessing for the use of EPT? 
3. Do you feel the process is being followed when providing EPT? 
4. What do you perceive as barriers to use of EPT? 
5. What questions do you want answered from my EPT program evaluation? 
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 Appendix E:  Online Survey Questions 
1. Did you complete the training for providing EPT, either via live webinar or the archived 
recording? 
a. Yes 
b. No 
2. Following the education, I felt prepared to use EPT in my clinical practice. (if yes to 1) 
a. Strongly Agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
3. Have you given EPT medications to a client? 
a. Yes 
b. No 
4. The reason(s) I have not provided EPT medications to a client are (choose all that apply).  
(if no to 3) 
a. I have not been trained in STI yet 
b. I have not been trained in EPT services yet 
c. I don’t believe in EPT 
d. My clients have all declined EPT 
e. I have not seen a client with a positive STI 
f. Other (Please explain) 
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 5. Please respond to the following statement:  EPT is being used fully to the extent it should 
be in SOPHN. 
a. Strongly Agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
6. Please respond to the following statement:  Using EPT increases the amount of clinical 
time vs using traditional contact investigation services. 
a. Strongly Agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
7. Please rate the following possible barriers to using EPT with clients. (Ratings:  I have not 
done this; No barrier; Slight barrier; Moderate barrier; strong barrier) 
a. Defining eligible clients for EPT services 
b. Explaining EPT services to clients 
c. Providing EPT medications for named partners 
d. Developing a tickler system for tracking the EPT process for 90 days 
e. Completing the 10 day phone call 
f. Charting the 10 day phone call 
g. Completing the 90 day phone call for retest 
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 h. Charting the 90 day phone call for retest 
i. Completing the 90 day retest appointment 
j. Charting the 90 day retest appointment 
8. What other concerns do you have about using EPT services (check all that apply)? 
a. Increased amount of clinical time to use EPT instead of traditional contact 
investigation 
b. Difficulty tracking client through the 90 day retest appointment 
c. Difficulty following standardized charting for EPT 
d. Fear of giving medications due to potential allergic reaction 
e. Fear it would decrease antimicrobial efficiency 
f. Concerns regarding the legal aspects of EPT 
g. No other concerns in using EPT 
h. Other (please explain) 
9. What suggestions do you have to improve the EPT process for SOPHN? 
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